Bioavailability of hCG after intramuscular or subcutaneous injection in obese and non-obese women | Zendy

CCY Chan | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Bioavailability of hCG after intramuscular or subcutaneous injection in obese and non-obese women

Author(s) -

CCY Chan

Publication year - 2003

Publication title -

human reproduction

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.446

H-Index - 226

eISSN - 1460-2350

pISSN - 0268-1161

DOI - 10.1093/humrep/deg446

Subject(s) - bioavailability , dosing , medicine , pharmacokinetics , intramuscular injection , body mass index , subcutaneous injection , ovulation , area under the curve , endocrinology , obesity , ethinylestradiol , hormone , pharmacology , population , environmental health , research methodology

Obese women require higher gonadotrophin doses for ovarian stimulation and to trigger ovulation. The bioavailability of a drug is affected by its route of administration. Herein, the bioavailability of hCG was compared after intramuscular (i.m.) or subcutaneous (s.c.) injection in obese and non-obese women.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research